Veterinary Oncology Market Set to Grow Rapidly, Projected to Reach USD 29.02 Billion by 2033

The global veterinary oncology market is poised for substantial growth, with an expected increase from USD 12.51 billion in 2024 to USD 29.02 billion by 2033, reflecting a compound annual growth rate (CAGR) of 9.8%. The rise in market size can be attributed to a combination of heightened awareness about pet cancer and the rapid advancement in veterinary cancer treatments.

Cancer has become a significant concern in pet health, with approximately one in four dogs and one in five cats being diagnosed with cancer during their lives, according to the American Veterinary Medical Association (AVMA). In response, global organizations and governments are increasing their focus on veterinary oncology. Programs such as the NCI Comparative Oncology Program have fostered collaboration between veterinary and human oncology research, enhancing the understanding and treatment of cancer across both fields.

Download Free Sample PDF Copy Of This Report@ https://www.emergenresearch.com/request-sample/3217

In 2022, public organizations allocated more than $10 million towards research in veterinary cancer, highlighting the growing importance of funding to advance new therapies, diagnostics, and medical research. Additionally, initiatives like the U.S. Department of Agriculture's Veterinary Services Grant Program continue to support the growth of veterinary oncology infrastructure, improving both treatment outcomes and overall awareness.

Market Drivers: Advancements in Treatments

The veterinary oncology market is largely driven by significant advancements in diagnostic and therapeutic technologies. Techniques such as precision medicine, immunotherapy, and targeted treatments are being adopted more widely in veterinary applications. Stereotactic radiation therapy (SRT), for example, offers high-precision radiation treatment that minimizes damage to surrounding healthy tissue, providing a promising alternative for treating tumors in pets.

Regulatory approvals for innovative treatments also support market growth. One example is the conditional approval of Tanovea-CA1 by the U.S. Food and Drug Administration, a treatment aimed at canine lymphoma. These advancements, along with the rise of advanced imaging technologies like CT and MRI scans, enable early cancer detection and tailored treatment plans, further driving demand for sophisticated veterinary oncology services.

Market Restraints: High Treatment Costs

Despite the market's growth, high treatment costs remain a major challenge. Cancer treatments such as chemotherapy, radiation therapy, and advanced imaging can cost pet owners between $5,000 and $10,000, depending on factors like tumor size and stage. For many pet owners, especially in areas where pet insurance is limited, these costs can be prohibitively expensive.

Additionally, government funding and subsidies tend to focus on zoonotic diseases, leaving chronic diseases like cancer with less financial support. This has led to limited access to advanced oncology treatments in underserved areas, which could slow the overall expansion of the market.

Chemotherapy Leads Market, Immunotherapy Shows Fastest Growth

The veterinary oncology market is segmented by therapy type into radiotherapy, surgery, chemotherapy, immunotherapy, and others. In 2023, chemotherapy accounted for the largest share of the market. Chemotherapy is the most common treatment for various types of cancers in animals, including lymphoma, osteosarcoma, and hemangiosarcoma, and is widely recommended by the AVMA.

However, immunotherapy is the fastest-growing segment of the market. Targeted therapies, including monoclonal antibodies and cancer vaccines, are gaining popularity due to their ability to offer more personalized treatment with fewer side effects. The adoption of immunotherapy is expected to continue expanding at a rapid pace as pet owners seek less invasive and more effective treatment options for their pets.

Request For Customization:  https://www.emergenresearch.com/request-for-customization/3217    

The competitive landscape of the report has been formulated by considering all the vital parameters such as company profiling, market share, recent developments and advancements, gross margins, product portfolio, revenue generation, financial standing, market position, and expansion plans. The report also discusses in detail the recent mergers and acquisitions, joint ventures, collaborations, product launches and brand promotions, agreements, corporate and government deals, and partnerships, among others. The report also sheds light on the recent technological developments and product advancements in the Veterinary Oncology market.

Furthermore, the report provides details about the new players entering the market, entry-level barriers and offers strategic recommendations to overcome those barriers to gain a substantial industry presence.

Some of the key companies in the global Veterinary Oncology Market include:

PetCure Oncology

Zoetis

Karyopharm Therapeutics, Inc.

Varian Medical Systems

Accuray Incorporated

Boehringer Ingelheim GmbH

Elanco

One Health

Regeneus Ltd.

The global Veterinary Oncology market report covers the analysis of drivers, trends, limitations, restraints, and challenges arising in the Veterinary Oncology market. The report also discusses the impact of various other market factors affecting the growth of the market across various segments and regions. The report segments the market on the basis of types, applications, and regions to impart a better understanding of the Veterinary Oncology market.

Veterinary Oncology Market Segmentation Analysis

Animal Type Outlook (Revenue, USD Million; 2020-2033)

Canine

Feline

Equine

Therapy Outlook (Revenue, USD Million; 2020-2033)

Radiotherapy

Surgery

Chemotherapy

Immunotherapy

Other Therapies

Cancer Type Outlook (Revenue, USD Million; 2020-2033)

Skin Cancers

Lymphomas

Sarcomas

Others

Quick Buy- https://www.emergenresearch.com/select-license/3217      

The Global Veterinary Oncology Market is further analyzed across the key geographical locations where the market has expanded to a significant size. The key region analyzed are North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The report offers a country-wise analysis to provide a comprehensive analysis of the Veterinary Oncology market in terms of production and consumption patterns, supply and demand ratio, import/export, revenue contribution, trends, and presence of prominent players in each region.

By Regional Outlook (Revenue, USD Million; 2020-2033)

North America

United States

Canada

Mexico

Europe

Germany

France

United Kingdom

Italy

Spain

Benelux

Rest of Europe

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Latin America

Brazil

Rest of Latin America

Middle East and Africa

Saudi Arabia

UAE

South Africa

Turkey

Rest of MEA

The global Veterinary Oncology market is poised for significant growth, driven by increasing consumer awareness, supportive government policies, and advancements in manufacturing technologies. As businesses and consumers continue to prioritize sustainability, the demand for Veterinary Oncology solutions is expected to rise, creating opportunities for innovation and market expansion.

The veterinary oncology market is set for strong growth, driven by advancements in treatment options and increasing awareness of cancer as a serious pet health issue. Despite challenges such as high treatment costs and limited access to care in some regions, the market's overall trajectory remains positive, with innovations in chemotherapy and immunotherapy leading the way. As pet owners demand more sophisticated care for their animals, the veterinary oncology industry is positioned for continued growth and transformation.

14671 110 Avenue, Surrey, British Columbia, V3R2A9
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.